[TO BREATHE EASIER Patient with approved treatment for Cystic Fibrosis] |
For several years now,
scientists have continuously struggled to find a therapeutic treatment suitable
to aiding most victims of cystic fibrosis. Now, with a newfounded triple-drug
approach, although still being tested, scientists are one step closer to a revolutionary
uncovery.
Cystic fibrosis, a
mutation in a gene also known as CFTR, forces the body to either produce
defective versions of a protein, or none at all. With the hereditary disorder
affecting the exocrine glands, an abnormally thick mucus is generated, and thus
the pancreatic ducts as well as intestines are blocked.
So how can this be
treated?
Well, as of recent
laboratory studies conducted, two triple-drug approaches, both of which
underwent processes of four week periods, showed a breakthrough with the
improvement in lung function of people with the most common cystic
fibrosis-causing mutation. About 90% of people with the disease have this
mutation, and so with continued testing, this particular non-invasive
triple-drug combination could potentially provide an effective treatment for
the vast majority of cystic fibrosis patients.
This new triple-drug
treatment builds upon the success of an earlier drug, that of which had been
approved in 2012 for patients who had a much less common mutation. This
particular treatment achieved high rates of success, as proven with detailed
data analysis. Steven Rowe, a pulmonologist at the University of Alabama
states, “They are in the hospital much less,” he says, and “the way they feel
on a day-to-day basis is substantially improved.”
Thus, with the oncoming
development of the triple-drug treatment, scientists are predicting a
breakthrough in cystic fibrosis treatments, with some believing that, once
approved, it will be life-changing for over 90% of patients living with cystic
fibrosis.
Credit:
Cunningham, Aimee. “New Therapies Pack a Triple-Drug Punch to Treat
Cystic Fibrosis.” Science News, Science News Organization, 19 Oct. 2018, www.sciencenews.org/article/new-therapies-pack-triple-drug-punch-treat-cystic-fibrosis?tgt=nr.
Image Credit:
News, CKOM. “Mom Reacts as Coverage Denied for $240K Cystic Fibrosis
Drug.” 650 CKOM, www.ckom.com/2018/10/18/422789/
No comments:
Write comments